[HIV plus hepatitis C or Kaposi sarcoma. Treatment options in coinfection].
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000009:adverse effects; D018450:Disease Progression; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D012514:Sarcoma, Kaposi / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*
D019380:Anti-HIV Agents; D000970:Antineoplastic Agents; D000998:Antiviral Agents
HIV plus Hepatitis C oder Kaposi Sarkom. Behandlungsoptionen bei Koinfektionen.